NAEUN HOSPITAL
Chronic pain treatment cost in South Korea typically depends on the underlying condition and chosen technology, with a spinal cord stimulator (SCS) costing between AUD $24,300 and AUD $24,300 while stem cell therapy for chronic pain runs from AUD $6,400 to AUD $12,200. Patients usually save 40–60% compared to private costs in Australia. Major medical hubs include Seoul and Incheon.
Typical Chronic Pain Treatment Costs in South Korea
Bookimed Expert Insight: Patients with neurodegenerative disorders or spinal stenosis find unique value in South Korea. Specialist clinics like RE:YOUTH offer exclusive arterial infusion techniques for stem cells. Larger multidisciplinary centres like Severance Hospital provide high-volume surgical expertise with over 40,000 annual operations. JCI-accredited facilities in Seoul allow Australian patients to access advanced pain management technologies not always available locally under Medicare.
| Republic of Korea | Thailand | Turkey | |
| Stem cell therapy for chronic pain | ≈ AUD $6,400 | from AUD $2,100 | ≈ AUD $9,300 |
| Spinal cord stimulator (SCS) | ≈ AUD $24,300 | ≈ AUD $26,500 | from AUD $22,900 |
| Microcurrent Therapy | ≈ AUD $210 | ≈ AUD $640 | ≈ AUD $640 |
No hidden fees – just official clinic prices. Pay at the clinic for Chronic pain treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chronic pain treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chronic pain treatment journey.
Dr Byung-hee Lee has performed over 900 procedures and is a founding member of both the Korean Stroke Society and the Korean Society of Interventional Neurology.
Chronic pain treatment in the Republic of Korea combines regenerative therapies with interventional neurology. Specialists provide arterial stem cell therapy, nerve blocks, and spinal cord stimulators (SCS). JCI-accredited hospitals like Severance Hospital integrate multidisciplinary rehabilitation with digital imaging for targeted pain relief.
Bookimed Expert Insight: While many countries offer stem cell therapy, South Korean clinics like RE:YOUTH specialise in arterial delivery. This method delivers cells to specific organs or tissues more effectively. Dr Byung-hee Lee, a founding member of the Korean Society of Interventional Neurology, pioneered these precise infusion techniques to improve outcomes.
Patient Consensus: Patients find that Korean clinics typically start with conservative medication before moving to imaging-guided injections. Many note that pairing traditional manual therapy with hospital-based rehabilitation provides the most consistent long-term relief.
Traditional Korean Medicine is a primary choice for chronic pain because it is integrated with Western medicine. South Korea uses a dual healthcare system. This allows patients to combine acupuncture, herbal remedies, and manual Chuna therapy with regenerative treatments like stem cell therapy.
Bookimed Expert Insight: Chronic pain management in Korea is evolving through hybrid clinics like RE:YOUTH (YONSEI BH Arterial Stemcell Clinic). These centres bridge the gap between tradition and innovation. Many patients seek acupuncture, but specialists like Dr Byung-hee Lee now offer arterial stem cell therapy. This approach uses the body’s own healing mechanisms. It serves as a modern alternative to traditional herbal anti-inflammatory protocols.
Patient Consensus: Patients in Korea often use traditional therapies alongside conventional care for persistent joint pain. They value longer appointment times. They also appreciate the focus on multi-modal symptom relief instead of just surgery.
The Republic of Korea offers specialised chronic pain care at JCI-accredited facilities. These include Severance Hospital and Gachon University Gil Medical Center. These centres use interventional techniques and regenerative therapies. Australian patients can access specialists without a GP referral for faster diagnosis and treatment.
Bookimed Expert Insight: Major hospitals in Seoul handle massive patient volumes. However, RE:YOUTH in Cheonan limits intake to just two patients daily. This focus allows for personalised attention during intensive arterial stem cell therapy. Patients seeking more specialist time may find this boutique approach very effective.